Missed GME or NVDA? Donโt Miss the Next One.โ
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities โ for free.
Home โบ Stocks โบ Eastman Chemical Company (EMN) Stock Forecast & Price Prediction United States | NYSE | Basic Materials | Specialty Chemicals
$81.25
+0.44 (0.54%)10 Quality Stocks Worth Considering Now
Researching Eastman (EMN) after the drop? Our ex-Goldman Sachs analyst reveals if it made our list of 10 oversold quality stocks with strong growth potential.
Get our FREE market selloff report + exclusive analysis on EMN and similar high-potential opportunities.
Based on our analysis of 27 Wall Street analysts, EMN has a bullish consensus with a median price target of $92.50 (ranging from $76.00 to $118.00). The overall analyst rating is Strong Buy (8.3/10). Currently trading at $81.25, the median forecast implies a 13.8% upside. This outlook is supported by 13 Buy, 7 Hold, and 0 Sell ratings.
The most optimistic forecast comes from Michael Sison at Wells Fargo, projecting a 45.2% upside. Conversely, the most conservative target is provided by Jeffrey Zekaukas at JP Morgan, suggesting a 6.5% downside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
These are the latest 20 analyst ratings and price targets for EMN.
Date | Firm | Analyst | Rating | Change | Price Target |
---|---|---|---|---|---|
Apr 29, 2025 | Barclays | Michael Leithead | Equal-Weight | Maintains | $85.00 |
Apr 28, 2025 | JP Morgan | Jeffrey Zekaukas | Neutral | Downgrade | $76.00 |
Apr 28, 2025 | Morgan Stanley | Vincent Andrews | Overweight | Maintains | $115.00 |
Apr 28, 2025 | Keybanc | Aleksey Yefremov | Overweight | Maintains | $106.00 |
Apr 28, 2025 | Goldman Sachs | Duffy Fischer | Neutral | Maintains | $87.00 |
Apr 14, 2025 | Keybanc | Aleksey Yefremov | Overweight | Maintains | $120.00 |
Apr 9, 2025 | Wells Fargo | Michael Sison | Overweight | Maintains | $90.00 |
Apr 7, 2025 | UBS | Joshua Spector | Buy | Maintains | $115.00 |
Apr 7, 2025 | Piper Sandler | Charles Neivert | Neutral | Maintains | $99.00 |
Apr 4, 2025 | Citigroup | Patrick Cunningham | Buy | Upgrade | $101.00 |
Apr 3, 2025 | Mizuho | John Roberts | Outperform | Upgrade | $105.00 |
Feb 13, 2025 | Piper Sandler | Charles Neivert | Neutral | Maintains | $105.00 |
Feb 4, 2025 | RBC Capital | Arun Viswanathan | Sector Perform | Maintains | $103.00 |
Feb 3, 2025 | Barclays | Michael Leithead | Equal-Weight | Maintains | $108.00 |
Feb 3, 2025 | Keybanc | Aleksey Yefremov | Overweight | Maintains | $128.00 |
Feb 3, 2025 | JP Morgan | Jeffrey Zekaukas | Overweight | Maintains | $112.00 |
Jan 31, 2025 | UBS | Joshua Spector | Buy | Maintains | $123.00 |
Jan 14, 2025 | B of A Securities | Steve Byrne | Buy | Upgrade | $109.00 |
Jan 7, 2025 | Piper Sandler | Charles Neivert | Neutral | Maintains | $102.00 |
Dec 18, 2024 | Citigroup | Patrick Cunningham | Neutral | Downgrade | $104.00 |
The following stocks are similar to Eastman based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Eastman Chemical Company has a market capitalization of $9.33B with a P/E ratio of 10.3x. The company generates $9.36B in trailing twelve-month revenue with a 9.8% profit margin.
Revenue growth is -0.9% quarter-over-quarter, while maintaining an operating margin of +13.9% and return on equity of +16.0%.
Get All 10 Quality Stocks For This Market Selloff
Still researching investments after the market drop? Our ex-Goldman Sachs analyst has already identified the 10 highest-quality oversold stocks with strong fundamentals and upside potential.
Why spend hours researching when we've already done the work? Get instant access to our complete market selloff analysis.
Produces specialty materials and chemicals.
Eastman Chemical Company generates revenue by developing and selling a diverse range of specialty materials, including additives, advanced materials, and fibers. The company leverages its technological expertise to innovate and enhance product formulations, addressing the specific needs of various industries such as automotive, healthcare, and construction.
Founded in 1920 and headquartered in Kingsport, Tennessee, Eastman is committed to sustainability and innovation, focusing on circular economy strategies. The company plays a key role in promoting safety, performance, and resource efficiency in its product offerings.
Basic Materials
Specialty Chemicals
14,000
Mr. Mark J. Costa
United States
1993
Eastman Chemical Company (NYSE: EMN) has declared a quarterly cash dividend of $0.83 per share on its common stock, as announced by its Board of Directors.
Eastman Chemical's quarterly dividend of $0.83 per share signals financial stability and commitment to returning value, which can attract income-focused investors and support stock price stability.
Eastman Chemical Company (NYSE: EMN) announced the results of its stockholder vote from the 2025 Annual Meeting.
The stockholder vote results may impact Eastman Chemical's governance and strategic direction, influencing investor confidence and stock performance.
JP Morgan analyst Jeffrey J. Zekauskas downgraded Eastman Chemical Company (EMN) from Overweight to Neutral, reducing the price target from $112.00 to $76.00.
The downgrade of Eastman Chemical by JP Morgan signals reduced growth expectations, potentially leading to a decline in stock price and investor confidence.
Eastman Chemical Company will hold its Q1 2025 earnings conference call on April 25, 2025, at 8:00 AM ET, featuring key executives and analysts from major financial institutions.
The Q1 2025 earnings call for Eastman Chemical will provide insights into financial performance and strategic direction, influencing investor sentiment and stock valuation.
EMN's sales volume in Q1 was affected by customer inventory destocking, particularly in its acetate tow products.
Customer inventory destocking in acetate tow products may indicate reduced demand, potentially affecting EMN's revenue and profitability, which could influence investor sentiment and stock performance.
Eastman Chemical (EMN) reported Q3 earnings of $1.91 per share, surpassing the Zacks Consensus Estimate of $1.89 and up from $1.61 per share year-over-year.
Eastman Chemical's earnings beat expectations and show year-over-year growth, signaling strong performance and potential for future profitability, which can boost investor confidence and stock value.
Based on our analysis of 27 Wall Street analysts, Eastman Chemical Company (EMN) has a median price target of $92.50. The highest price target is $118.00 and the lowest is $76.00.
According to current analyst ratings, EMN has 13 Buy ratings, 7 Hold ratings, and 0 Sell ratings. The stock is currently trading at $81.25. Always conduct your own research and consider your investment goals before making investment decisions.
Wall Street analysts predict EMN stock could reach $92.50 in the next 12 months. This represents a 13.8% increase from the current price of $81.25. Please note that this is a projection by Wall Street analysts and not a guarantee.
Eastman Chemical Company generates revenue by developing and selling a diverse range of specialty materials, including additives, advanced materials, and fibers. The company leverages its technological expertise to innovate and enhance product formulations, addressing the specific needs of various industries such as automotive, healthcare, and construction.
The highest price target for EMN is $118.00 from Michael Sison at Wells Fargo, which represents a 45.2% increase from the current price of $81.25.
The lowest price target for EMN is $76.00 from Jeffrey Zekaukas at JP Morgan, which represents a -6.5% decrease from the current price of $81.25.
The overall analyst consensus for EMN is bullish. Out of 27 Wall Street analysts, 13 rate it as Buy, 7 as Hold, and 0 as Sell, with a median price target of $92.50.
Stock price projections, including those for Eastman Chemical Company, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.